Lytix Biopharma AS (LYTIX.OL) Stock Price
Lytix Biopharma AS Price
Revenue has compounded at 39.9% per year over the past 7 years to 11.13 M NOK. Lytix Biopharma AS's net margin stands at -846.6%, up from -1,402,933.4% several years earlier. Analysts set a median price target of 13.06 NOK, implying 69.2% above the current price. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
Lytix Biopharma AS stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Lytix Biopharma AS business model & stock analysis
Frequently asked questions about Lytix Biopharma AS
Analysts currently set an average price target of 13.06 NOK for the Lytix Biopharma AS stock (median: 13.06 NOK), implying +68.8 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Lytix Biopharma AS stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Lytix Biopharma AS to generate revenue of 12.55 M NOK and earnings per share of -2.68 NOK.
Converted at the current exchange rate, the Lytix Biopharma AS share trades at 0.75 EUR (7.72 NOK).
The expected revenue of Lytix Biopharma AS is 12.55 M NOK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Lytix Biopharma AS is -103.82 M NOK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Lytix Biopharma AS is currently -2.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Lytix Biopharma AS stock.
The price-to-sales ratio (P/S) of Lytix Biopharma AS is currently 23.83. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Lytix Biopharma AS stock.
The Eulerpool Quality Score for Lytix Biopharma AS is 3/10.
The ISIN of Lytix Biopharma AS is NO0010405780. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Lytix Biopharma AS is A3CSAK. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Lytix Biopharma AS is LYTIX.OL. The ticker symbol is used to trade Lytix Biopharma AS shares on the stock exchange.
Lytix Biopharma AS stock
Lytix Biopharma AS Peer Group
Lytix Biopharma AS FIGI
All fundamentals and in-depth analysis of Lytix Biopharma AS
Our stock analysis for Lytix Biopharma AS stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lytix Biopharma AS. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.